News

Laura Loomer Blasts Return of FDA Vaccine Chief She Helped Force Out
Loomer is an influential figure in right-wing circles. She was present alongside Trump on the 2024 campaign trail, and she ...
FDA official returns to agency after Loomer-led ouster
Dr. Vinay Prasad, a controversial critic of the US Food and Drug Administration who took a top role at the regulatory agency ...
FDA regulator reinstalled less than two weeks after White House ouster
Vinay Prasad, the FDA’s top vaccine and gene therapy regulator, was the target of a right-wing pressure campaign over his ...
Fierce Pharma1d
Vinay Prasad is back at the FDA after last month's surprise ouster. Will he stay this time?
Vinay Prasad, M.D., has rejoined the FDA, the latest turn in a monthslong stretch of leadership turnover at the agency. | “At ...
A former FDA chief’s ‘brilliant’ move to test the agency’s commitment to making America healthy
The former head of the US Food and Drug Administration is testing the Trump administration’s commitment to “Make America ...
FDA Issues Highest Risk Warning For Nuts
Navarro Pecan Holdings, LLC issued a voluntary recall of 32,670 pounds of pecan products on July 10 due to concerns about ...
STAT1d
In internal FDA town hall, employees raise concerns about staffing, impromptu expert meetings
Exclusive: FDA employees, in a town hall after the ouster of Vinay Prasad, asked about unusual meetings and staff shortages. ...
FDA launches program to encourage American drug manufacturing
The U.S. Food and Drug Administration announced Thursday it is launching "FDA PreCheck" in order to help construct drug ...
FDA pulls popular ice cream from shelves after packaging mix up: ‘Serious allergic reaction’
DFA Dairy Brands, LLC pulled 324 cartons of its 48-fluid-ounce Friendly’s Cookies & Cream ice cream from stores after they were packaged in Vanilla Bean containers but topped with Cookies ...
Medical Dialogues3h
FDA Approves Ajovy® for Preventive Treatment of Episodic Migraine in Children Aged 6–17
The FDA has approved Ajovy® (fremanezumab-vfrm) for preventive treatment of episodic migraine in pediatric patients aged 6 to ...